Literature DB >> 11587683

Quality of life after pylorus-preserving pancreatoduodenectomy.

T Ohtsuka1, K Yamaguchi, K Chijiiwa, N Kinukawa, M Tanaka.   

Abstract

BACKGROUND: With increasing numbers of long-term survivors after pylorus-preserving pancreatoduodenectomy (PPPD), postoperative quality of life (QOL) has become a great concern. However, few reports are available on data of the postoperative changes in QOL after PPPD.
METHODS: A total of 20 patients were studied regarding QOL before and at short term (within 2 months), intermediate term (6 months), and long term (1 year) after PPPD, using a questionnaire. The questionnaire consisted of 13 physical and 10 psychosocial items. The medical records were also reviewed to evaluate objective nutritional status. Factors predicting delayed recovery of QOL were examined at intermediate term by univariate and multivariate analyses.
RESULTS: Overall and physical QOL scores returned to the preoperative level at intermediate term after PPPD, showing parallel changes with the objective nutritional status. However, the scores of psychosocial condition, which reflected the patient's mental health, remained low even at long term. QOL scores at intermediate term in patients with pancreatic carcinoma were significantly lower than those with other diseases. Univariate analysis showed that preoperative body weight loss, impaired preoperative pancreatic exocrine function, long operative time, intraoperative radiotherapy, pancreatic carcinoma, and postoperative diarrhea were factors predicting the delayed recovery of QOL. Multivariate analysis revealed that preoperative pancreatic exocrine function significantly affected the delayed recovery of QOL.
CONCLUSIONS: Preoperative supplement of pancreatic enzymes together with perioperative mental care would improve QOL at long term after PPPD.

Entities:  

Mesh:

Year:  2001        PMID: 11587683     DOI: 10.1016/s0002-9610(01)00709-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  The evaluation of duct-to-mucosal pancreaticojejunostomy in pancreaticoduodenectomy.

Authors:  Masaji Tani; Hironobu Onishi; Hiroyuki Kinoshita; Manabu Kawai; Masaki Ueno; Takashi Hama; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

2.  Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial.

Authors:  Masaji Tani; Hiroshi Terasawa; Manabu Kawai; Shinomi Ina; Seiko Hirono; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

3.  Antecolic gastrointestinal reconstruction with pylorus dilatation. Does it improve delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy?

Authors:  Konstantinos Manes; Dimitrios Lytras; Costas Avgerinos; Spiros Delis; Christos Dervenis
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 4.  Meta-analysis of subtotal stomach-preserving pancreaticoduodenectomy vs pylorus preserving pancreaticoduodenectomy.

Authors:  Wei Huang; Jun-Jie Xiong; Mei-Hua Wan; Peter Szatmary; Shameena Bharucha; Ilias Gomatos; Quentin M Nunes; Qing Xia; Robert Sutton; Xu-Bao Liu
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

5.  Complications with reconstruction procedures in pylorus-preserving pancreaticoduodenectomy.

Authors:  Masaji Tani; Manabu Kawai; Hiroshi Terasawa; Masaki Ueno; Takashi Hama; Seiko Hirono; Shinomi Ina; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

6.  Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis.

Authors:  Wesley H Greenblatt; Chin Hur; Amy B Knudsen; John A Evans; Daniel C Chung; G Scott Gazelle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

7.  A prospective, randomized, double-blind, placebo controlled trial on the efficacy of ethanol celiac plexus neurolysis in patients with operable pancreatic and periampullary adenocarcinoma.

Authors:  Harish Lavu; Harry B Lengel; Naomi M Sell; Joseph A Baiocco; Eugene P Kennedy; Theresa P Yeo; Sherry A Burrell; Jordan M Winter; Sarah Hegarty; Benjamin E Leiby; Charles J Yeo
Journal:  J Am Coll Surg       Date:  2014-12-17       Impact factor: 6.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.